We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Protective Immunity and New Vaccines for Lyme Disease.
- Authors
Gomes-Solecki, Maria; Arnaboldi, Paul M; Backenson, P Bryon; Benach, Jorge L; Cooper, Christopher L; Dattwyler, Raymond J; Diuk-Wasser, Maria; Fikrig, Erol; Hovius, J W; Laegreid, Will; Lundberg, Urban; Marconi, Richard T; Marques, Adriana R; Molloy, Philip; Narasimhan, Sukanya; Pal, Utpal; Pedra, Joao H F; Plotkin, Stanley; Rock, Daniel L; Rosa, Patricia
- Abstract
Lyme disease, caused by some Borrelia burgdorferi sensu lato , is the most common tick-borne illness in the Northern Hemisphere and the number of cases, and geographic spread, continue to grow. Previously identified B. burgdorferi proteins, lipid immunogens, and live mutants lead the design of canonical vaccines aimed at disrupting infection in the host. Discovery of the mechanism of action of the first vaccine catalyzed the development of new strategies to control Lyme disease that bypassed direct vaccination of the human host. Thus, novel prevention concepts center on proteins produced by B. burgdorferi during tick transit and on tick proteins that mediate feeding and pathogen transmission. A burgeoning area of research is tick immunity as it can unlock mechanistic pathways that could be targeted for disruption. Studies that shed light on the mammalian immune pathways engaged during tick-transmitted B. burgdorferi infection would further development of vaccination strategies against Lyme disease.
- Subjects
LYME disease prevention; DISEASE vectors; HEALTH education; IMMUNE system; IMMUNIZATION; LIPIDS; LYME disease; MEMBRANE proteins; POPULATION geography; PUBLIC health; TICKS; DRUG development
- Publication
Clinical Infectious Diseases, 2020, Vol 70, Issue 8, p1768
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciz872